检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
20期
2858-2859
,共2页
柯苑%赵静%马成平%黄敏%姚慧兰%张立波%马贵明
柯苑%趙靜%馬成平%黃敏%姚慧蘭%張立波%馬貴明
가원%조정%마성평%황민%요혜란%장립파%마귀명
血液筛查%核酸检测技术%“窗口期”%转录介导扩增技术
血液篩查%覈痠檢測技術%“窗口期”%轉錄介導擴增技術
혈액사사%핵산검측기술%“창구기”%전록개도확증기술
blood screening%nucleic acid detection technology%window period%transcription-mediated amplification
目的:采取核酸检测(NAT )技术进行血液筛查,减少由献血者感染“窗口期”及隐匿感染献血引起的疾病传播。方法采用酶联免疫吸附法(ELISA)对54358份献血者标本进行乙型肝炎表面抗原(HBsAg)、人类免疫缺陷病毒抗体(抗-HIV)、丙型肝炎病毒抗体(HCV-Ab)检测,同时用转录介导扩增技术(TMA)进行 HBV-DNA 、HCV-RNA 检测,人类免疫缺陷病毒1型(HIV-1)RNA 核酸检测。结果 NAT 检测阳性 ELISA 检测阴性标本共51份。51份标本有鉴别试验结果的33份,其中32份 HBV-DNA 阳性,1份 HIV-1 RNA 阳性,HIV-1 RNA 阳性的献血者经南京市疾病预防控制中心免疫印迹法确认为 HIV-1疑似阳性(gp160和 p24±)。半年后再次回访该献血者,抽取血样送南京市疾控中心经免疫印迹法确认为 HIV-1阳性(gp160、gp120、p66、p51、gp41、p31、p24、p17+)。结论 NAT 技术可以减少由献血者感染“窗口期”及隐匿感染献血引起的疾病传播,从而减少输血风险。
目的:採取覈痠檢測(NAT )技術進行血液篩查,減少由獻血者感染“窗口期”及隱匿感染獻血引起的疾病傳播。方法採用酶聯免疫吸附法(ELISA)對54358份獻血者標本進行乙型肝炎錶麵抗原(HBsAg)、人類免疫缺陷病毒抗體(抗-HIV)、丙型肝炎病毒抗體(HCV-Ab)檢測,同時用轉錄介導擴增技術(TMA)進行 HBV-DNA 、HCV-RNA 檢測,人類免疫缺陷病毒1型(HIV-1)RNA 覈痠檢測。結果 NAT 檢測暘性 ELISA 檢測陰性標本共51份。51份標本有鑒彆試驗結果的33份,其中32份 HBV-DNA 暘性,1份 HIV-1 RNA 暘性,HIV-1 RNA 暘性的獻血者經南京市疾病預防控製中心免疫印跡法確認為 HIV-1疑似暘性(gp160和 p24±)。半年後再次迴訪該獻血者,抽取血樣送南京市疾控中心經免疫印跡法確認為 HIV-1暘性(gp160、gp120、p66、p51、gp41、p31、p24、p17+)。結論 NAT 技術可以減少由獻血者感染“窗口期”及隱匿感染獻血引起的疾病傳播,從而減少輸血風險。
목적:채취핵산검측(NAT )기술진행혈액사사,감소유헌혈자감염“창구기”급은닉감염헌혈인기적질병전파。방법채용매련면역흡부법(ELISA)대54358빈헌혈자표본진행을형간염표면항원(HBsAg)、인류면역결함병독항체(항-HIV)、병형간염병독항체(HCV-Ab)검측,동시용전록개도확증기술(TMA)진행 HBV-DNA 、HCV-RNA 검측,인류면역결함병독1형(HIV-1)RNA 핵산검측。결과 NAT 검측양성 ELISA 검측음성표본공51빈。51빈표본유감별시험결과적33빈,기중32빈 HBV-DNA 양성,1빈 HIV-1 RNA 양성,HIV-1 RNA 양성적헌혈자경남경시질병예방공제중심면역인적법학인위 HIV-1의사양성(gp160화 p24±)。반년후재차회방해헌혈자,추취혈양송남경시질공중심경면역인적법학인위 HIV-1양성(gp160、gp120、p66、p51、gp41、p31、p24、p17+)。결론 NAT 기술가이감소유헌혈자감염“창구기”급은닉감염헌혈인기적질병전파,종이감소수혈풍험。
Objective To explore the value of nucleic acid detection technology (NAT ) for blood screening to decrease the infection induced by blood donors in the window period and infected insidiously .Methods A total of 54 358 blood samples were detected by ELISA for hepatitis B surface antigen (HBsAg) ,antibody of human immuno-deficiency virus (HIV-Ab ) ,antibody of hepatitis C virus (anti-HCV ) ,and transcription-mediated amplification (TMA)method were used to detecte the DNA of hepatitis B virus (HBV-DNA ) ,the RNA of hepatitis C virus (HCV-RNA)and the RNA of type 1 human immunodeficiency virus(HIV-1 RNA) .Results Fifty-one samples were positive by NAT ,but negative by ELISA .A total of 33 samples in these 51 samples were identified .The HBV-DNA of 32 donors were positive ,and the HIV-1 RNA of one donor was positive ,who was identified as suspected HIV-1 positive (gp160 and p24 ± ) by western blot method in Nanjing municipal center for disease control and prevention . Six months later ,this blood donor was identified as HIV-1 positive (gp160 ,gp120 ,p66 ,p51 ,gp41 ,p31 ,p24 ,p17 + ) by western blot method in Nanjing municipal center for disease control and prevention .Conclusion NAT could effec-tively decrease the infection induced by blood donors in the window period and infected insidiously ,so as to reduce the risk of blood transfusion .